et al., Nature, doi:10.1038/s41467-021-22446-z (Peer Reviewed) (meta analysis - not included in study count)
Meta analysis assigning 89% weight to the RECOVERY and SOLIDARITY trials, producing the same result. These trials used excessively high non-patient-customized dosage in very sick late stage patients, results are not generalizable to typical dosage or earlier treatment.
For CQ, this study assigns 97% weight to Borba et al., however this study does not have a control group, comparing two different dosages of CQ.
Of the 29 early treatment trials (including 6 RCTs), authors include the results of only one where they include a non-hospitalized death.
Axfors et al., 9/18/2020, peer-reviewed, 97 authors.